Indogulf Cropsciences Limited — Investor Meet, 21-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Indogulf Cropsciences saw Q1 FY27 revenue decline 11% YoY to Rs. 168.5 Cr due to delayed monsoons. Despite this, gross margins improved significantly to 28% and EBITDA margins to 5.7%, reflecting strong cost and product mix discipline. PAT was Rs. 2.4 Cr. Management views Q1 weakness as temporary, focusing on expanding high-margin biologicals, specialty products, and international markets. Capacity utilization rose to 70%, with 34% captive technical usage for efficiency. The company aims to evolve into an integrated agri-solution platform, targeting Rs. 1800 Cr+ revenue in 4-5 years. The outlook remains strategically driven for long-term growth.